NCI-H841 [H841] from ATCC

Product Specs
ItemNCI-H841 [H841]
CompanyATCC
Price $551.00Supplier Page View Company Product Page
Catalog NumberCRL-5845
TypeCell Biology
SpeciesHomo sapiens
TissueLung
Cell LineNCI-H841
Validated Species ReactivityHuman (Hu)
Tissue (standardized)Lung
Age51 years
DiseaseCarcinoma Variant small cell lung cancer Stage L
ApplicationsThe line was established in October 1984

Specifications/Features

Post freeze viability ≥ 50%

Add to Compare List

ATCC

10801 University Boulevard

Manassas, Virginia 20110-2209

United States

Phone: (703) 365-2700
Fax: (703) 365-2701

Company Profile

Website: http://www.atcc.org

(1) The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung CancerInternational journal of molecular sciencesFebruary 3, 2025Iñañez A, Del Rey-Vergara R, Quimis F, Rocha P, Galindo M, Menéndez S, Masfarré L, Sánchez I, Carpes M, Martínez C, et al.from the European Collection of Authenticated Cell Cultures (ECACC). The H841 cell line (ATCC number: CRL-5845, RRID: CVCL_1595) was generously provided by Dr. Montse Sánchez (Institut Josep Carreras, Badalona,

(2) Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypesCancer CellFebruary 1, 2024Simon Heeke, Carl M. Gay, Marcos R. Estecio, Hai Tran, Benjamin B. Morris, Bingnan Zhang, Ximing Tang, Maria Gabriela Raso, Pedro Rocha, Siqi Lai, et al.H211,ATCC,Cat # CRL-5824 Human cell line: H196,ATCC,Cat # CRL-5823 Human cell line: H841,ATCC,Cat # CRL-5845 Human cell line: DMS114,ATCC,Cat # CRL-2066 Human cell line: H1930,ATCC,Cat # CRL-5906 Human cell

(3) Multicellular complex tumor spheroid response to DNA repair inhibitors in combination with DNA-damaging drugsCancer Research CommunicationsAugust 25, 2023Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, John Wright, Joel Morris, James H. Doroshow, Beverly A. TeicherRRID:CVCL_1582), NCI-H196 (ATCC, catalog no. CRL-5823, RRID:CVCL_1509), NCI-H841 (ATCC, catalog no. CRL-5845, RRID:CVCL_1595), NCI-H1618 (ATCC, catalog no. CRL-5879, RRID:CVCL_1480), NCI-H1876 (ATCC, catalog no.

(4) Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging DrugsCancer Res CommunAugust 25, 2023Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, John Wright, Joel Morris, James H. Doroshow, Beverly A. TeicherRRID:CVCL_1582), NCI-H196 (ATCC, catalog no. CRL-5823, RRID:CVCL_1509), NCI-H841 (ATCC, catalog no. CRL-5845, RRID:CVCL_1595), NCI-H1618 (ATCC, catalog no. CRL-5879, RRID:CVCL_1480), NCI-H1876 (ATCC, catalog no.

(5) MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancerCell reports. MedicineApril 18, 2023Alburquerque-Bejar JJ, Navajas-Chocarro P, Saigi M, Ferrero-Andres A, Morillas JM, Vilarrubi A, Gomez A, Mate JL, Munoz-Marmol AM, Romero OA, et al.HTB-182 H522,ATCC,Cat# CRL-5810 H69,ATCC,Cat# HTB-119 H774,ATCC,Cat# CRL-5842 H82,ATCC,Cat# HTB-175 H841,ATCC,Cat# CRL-5845 HCC33,DMSZ,Cat# ACC 487 LUDLU1,ECACC,Cat# 92012463 PC14,ECACC,Cat# 90071810 PDC11,Pros et al.15,N/A PDC12,Pros

(6) Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell linesCancer Biology & TherapyDecember 31, 2022Clayton M. Wandishin, Charles John Robbins, Darren R. Tyson, Leonard A. Harris, Vito QuarantaH526, H841, H1048, and H1930 were purchased from the ATCC (ATCC CRL-2062, CRL-2066, CRL-5831, CRL-5811, CRL-5845, CRL-5853, CRL-5906). WM1799 cells were generously donated as a gift from the laboratory of Kim Dahlman,

(7) WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLCCell reportsMay 17, 2022Taniguchi H, Caeser R, Chavan SS, Zhan YA, Chow A, Manoj P, Uddin F, Kitai H, Qu R, Hayatt O, et al.CRL-5838, RRID:CVCL_1583" NCI-H524,ATCC,"ATCC Cat# CRL-5831, RRID:CVCL_1568" NCI-H841,ATCC,"ATCC Cat# CRL-5845, RRID:CVCL_1595" NCI-H526,ATCC,"ATCC Cat# CRL-5811, RRID:CVCL_1569" NCI-H1694,ATCC,"ATCC Cat# CRL-5888,

(8) Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCancer cellMarch 8, 2021Gay CM, Stewart CA, Park EM, Diao L, Groves SM, Heeke S, Nabet BY, Fujimoto J, Solis LM, Lu W, et al.H196 cells,ATCC,Cat # CRL-5823 Human: H526 cells,ATCC,Cat # CRL-5811 Human: H841 cells,ATCC,Cat # CRL-5845 Human: H82 cells,ATCC,Cat # HTB-175 Human: DMS79 cells,ATCC,Cat # CRL-2049 Human: H1930 cells,ATCC,Cat

(9) A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudilPloS oneJanuary 1, 2021Zhang J, Zhang S, Shi Q, Allen TD, You F, Yang D.American Type Culture Collection (ATCC, Manassas, VA, U.S.A.) include Hela (ATCC® CCL-2™), NCI-H841 (ATCC® CRL-5845™), DU-145 (ATCC® HTB-81™) and Calu-6 (ATCC® HTB-56™). Cells were grown for three passages and frozen

Be the First to Write a Review!

Description

Specifications/Features

ATCC

Citations (9)

Reviews

NCI-H841 [H841] from ATCC

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map